Cardiovascular disease prevention

Acta Clinica Belgica
|September 2, 2014
PubMed

Insights

Cardiovascular disease prevention efforts have succeeded in lowering mortality but remain challenged by aging populations and poor guideline adherence. Continued focus on prevention is crucial to reduce the high burden of these diseases.

Area of Science:

  • Cardiology
  • Public Health
  • Preventive Medicine

Background:

  • Cardiovascular diseases (CVDs) are the leading cause of death in Western countries.
  • While prevention, pharmaceuticals, and technology have reduced CVD mortality, increased life expectancy and poor adherence to guidelines maintain a high disease burden.
  • Addressing the persistent challenge of CVDs requires understanding current prevention strategies and adherence levels.

Purpose of the Study:

  • To summarize key European Society of Cardiology (ESC) prevention guidelines for cardiovascular diseases.
  • To assess the adherence to these ESC guidelines across different European countries using EUROASPIRE survey data.
  • To highlight the gap between recommended CVD prevention and actual practice.

Main Methods:

  • Literature review focusing on European Society of Cardiology (ESC) cardiovascular disease prevention guidelines.
  • Analysis of data from the EUROASPIRE surveys to evaluate guideline adherence.
  • Synthesis of information on mortality trends and contributing factors.

Main Results:

  • Significant progress in reducing cardiovascular disease mortality has been achieved through multifaceted approaches.
  • However, adherence to established European Society of Cardiology prevention guidelines remains notably incomplete across Europe.
  • Factors such as increased life expectancy and challenges in public/governmental engagement hinder comprehensive prevention.

Conclusions:

  • Despite successes, cardiovascular diseases continue to pose a significant public health challenge in Europe.
  • Incomplete adherence to evidence-based prevention guidelines is a critical barrier to further reducing CVD burden.
  • Enhanced implementation and adherence to ESC guidelines are essential for improving cardiovascular health outcomes.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
888
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
665
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.1K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
999